Search research articles
Contact Us
Filters
Showing results (51-60 of 81) with videos related to
Page
of 9
Sort By:
British Journal of Cancer
|
May 1, 1989
P-glycoprotein gene amplification and expression in multidrug-resistant murine P388 and B16 cell lines
G Capranico, P De Isabella, C Castelli, et al.
Molecular Pharmacology
|
July 1, 1990
Effects of morpholinyl doxorubicins, doxorubicin, and actinomycin D on mammalian DNA topoisomerases I and II
K Wassermann, J Markovits, C Jaxel, et al.
Biochemistry
|
January 9, 1996
Position-specific effects of base mismatch on mammalian topoisomerase II DNA cleaving activity
M Bigioni, F Zunino, S Tinelli, et al.
Molecular Pharmacology
|
May 1, 1993
Sequence selectivity of topoisomerase II DNA cleavage stimulated by mitoxantrone derivatives: relationships to drug DNA binding and cellular effects
P De Isabella, G Capranico, M Palumbo, et al.
Molecular Pharmacology
|
May 1, 1994
Influence of structural modifications at the 3' and 4' positions of doxorubicin on the drug ability to trap topoisomerase II and to overcome multidrug resistance
G Capranico, R Supino, M Binaschi, et al.
Cancer Research
|
May 15, 1998
Human DNA topoisomerase IIalpha-dependent DNA cleavage and yeast cell killing by anthracycline analogues
M Binaschi, R Farinosi, C A Austin, et al.
International Journal of Cancer
|
February 15, 1990
Comparison of DNA cleavage induced by etoposide and doxorubicin in two human small-cell lung cancer lines with different sensitivities to topoisomerase II inhibitors
M Binaschi, G Capranico, P De Isabella, et al.
International Journal of Cancer
|
May 8, 1993
A study of cross-resistance pattern and expression of molecular markers of multidrug resistance in a human small-cell lung-cancer cell line selected with doxorubicin
R Supino, M Binaschi, G Capranico, et al.
International Journal of Cancer
|
October 15, 1990
Relationships among tumor responsiveness, cell sensitivity, doxorubicin cellular pharmacokinetics and drug-induced DNA alterations in two human small-cell lung cancer xenografts
G Pratesi, G Capranico, M Binaschi, et al.
Molecular Pharmacology
|
December 18, 1998
DNA-binding preferences of bisantrene analogues: relevance to the sequence specificity of drug-mediated topoisomerase II poisoning
C Sissi, L Bolgan, S Moro, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 81) with videos related to
Sort By:
Page
of 9
British Journal of Cancer
|
May 1, 1989
P-glycoprotein gene amplification and expression in multidrug-resistant murine P388 and B16 cell lines
G Capranico, P De Isabella, C Castelli, et al.
Molecular Pharmacology
|
July 1, 1990
Effects of morpholinyl doxorubicins, doxorubicin, and actinomycin D on mammalian DNA topoisomerases I and II
K Wassermann, J Markovits, C Jaxel, et al.
Biochemistry
|
January 9, 1996
Position-specific effects of base mismatch on mammalian topoisomerase II DNA cleaving activity
M Bigioni, F Zunino, S Tinelli, et al.
Molecular Pharmacology
|
May 1, 1993
Sequence selectivity of topoisomerase II DNA cleavage stimulated by mitoxantrone derivatives: relationships to drug DNA binding and cellular effects
P De Isabella, G Capranico, M Palumbo, et al.
Molecular Pharmacology
|
May 1, 1994
Influence of structural modifications at the 3' and 4' positions of doxorubicin on the drug ability to trap topoisomerase II and to overcome multidrug resistance
G Capranico, R Supino, M Binaschi, et al.
Cancer Research
|
May 15, 1998
Human DNA topoisomerase IIalpha-dependent DNA cleavage and yeast cell killing by anthracycline analogues
M Binaschi, R Farinosi, C A Austin, et al.
International Journal of Cancer
|
February 15, 1990
Comparison of DNA cleavage induced by etoposide and doxorubicin in two human small-cell lung cancer lines with different sensitivities to topoisomerase II inhibitors
M Binaschi, G Capranico, P De Isabella, et al.
International Journal of Cancer
|
May 8, 1993
A study of cross-resistance pattern and expression of molecular markers of multidrug resistance in a human small-cell lung-cancer cell line selected with doxorubicin
R Supino, M Binaschi, G Capranico, et al.
International Journal of Cancer
|
October 15, 1990
Relationships among tumor responsiveness, cell sensitivity, doxorubicin cellular pharmacokinetics and drug-induced DNA alterations in two human small-cell lung cancer xenografts
G Pratesi, G Capranico, M Binaschi, et al.
Molecular Pharmacology
|
December 18, 1998
DNA-binding preferences of bisantrene analogues: relevance to the sequence specificity of drug-mediated topoisomerase II poisoning
C Sissi, L Bolgan, S Moro, et al.
Page
of 9